CHARACTERIZATION OF DYSKINESIAS INDUCED BY L-DOPA IN MPTP-TREATED SQUIRREL-MONKEYS

被引:51
|
作者
BOYCE, S
RUPNIAK, NMJ
STEVENTON, MJ
IVERSEN, SD
机构
[1] Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, CM20 2QR, Essex, Terlings Park
关键词
Chorea; Dystonia; l-dopa; Parkinson's disease; Squirrel monkey;
D O I
10.1007/BF02245739
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent treatment with l-dopa over a 2-year period induced abnormal involuntary movements in MPTP-treated squirrel monkeys. Dyskinesias included a choreic and dystonic component. Dose-response curves for chorea and dystonia revealed that the same dose of l-dopa (30 mg/kg) induced the highest score for both dyskinesias; however, the severity was much greater for chorea. Choreic movements were always most prevalent at the time of peak effect, whereas dystonia was apparent at the time of peak effect and at "end-of-dose", and was occasionally observed spontaneously. Our findings indicate that squirrel monkeys treated with MPTP develop l-dopa-induced dyskinesias which closely resemble those observed in Parkinson's disease. This species provides a valuable animal model to develop improved therapeutic agents. © 1990 Springer-Verlag.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 50 条
  • [1] NB-355 - A NOVEL PRODRUG FOR L-DOPA WITH REDUCED RISK FOR PEAK-DOSE DYSKINESIAS IN MPTP-TREATED SQUIRREL-MONKEYS
    TYE, SJ
    RUPNIAK, NMJ
    NARUSE, T
    MIYAJI, M
    IVERSEN, SD
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 393 - 403
  • [2] NIGROSTRIATAL DAMAGE IS REQUIRED FOR INDUCTION OF DYSKINESIAS BY L-DOPA IN SQUIRREL-MONKEYS
    BOYCE, S
    RUPNIAK, NMJ
    STEVENTON, MJ
    IVERSEN, SD
    CLINICAL NEUROPHARMACOLOGY, 1990, 13 (05) : 448 - 458
  • [3] EFFECT OF NONDOPAMINERGIC DRUGS ON L-DOPA-INDUCED DYSKINESIAS IN MPTP-TREATED MONKEYS
    GOMEZMANCILLA, B
    BEDARD, PJ
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 (05) : 418 - 427
  • [4] CHRONIC L-DOPA ADMINISTRATION INDUCES DYSKINESIAS IN THE MPTP-TREATED MARMOSET
    PEARCE, RKB
    JACKSON, M
    SMITH, L
    JENNER, P
    MARSDEN, CD
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U77 - U77
  • [5] EFFECT OF ESTROGEN AND PROGESTERONE ON L-DOPA INDUCED DYSKINESIA IN MPTP-TREATED MONKEYS
    GOMEZMANCILLA, B
    BEDARD, PJ
    NEUROSCIENCE LETTERS, 1992, 135 (01) : 129 - 132
  • [6] L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys
    Soghomonian, JJ
    Pedneault, S
    Blanchet, PJ
    Goulet, M
    DiPaolo, T
    Bedard, PJ
    MOLECULAR BRAIN RESEARCH, 1996, 39 (1-2): : 237 - 240
  • [7] Effects of E2007 on L-DOPA induced dyskinesia in MPTP-treated cynomolgus monkeys
    Mizuta, E.
    Ueno, M.
    Hanada, T.
    Kuno, S.
    MOVEMENT DISORDERS, 2006, 21 : S638 - S638
  • [8] Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys
    Arai, N
    Isaji, M
    Kojima, M
    Mizuta, E
    Kuno, S
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (11) : 1307 - 1316
  • [9] Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
    Fernagut, Pierre-Olivier
    Li, Qin
    Dovero, Sandra
    Chan, Piu
    Wu, Tao
    Ravenscroft, Paula
    Hill, Michael
    Chen, Zhenwen
    Bezard, Erwan
    PLOS ONE, 2010, 5 (11):
  • [10] ANTIPARKINSONIAN ACTIVITY OF TALIPEXOLE IN MPTP-TREATED MONKEYS - IN COMBINATION WITH L-DOPA AND AS CHRONIC TREATMENT
    IRIFUNE, M
    NOMOTO, M
    FUKUDA, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (02) : 117 - 123